Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9β-Hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist
- 9 September 2010
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (19) , 6996-7010
Abstract
In pursuit of a more detailed understanding of the structural requirements for the key side chain cannabinoid pharmacophore, we have extended our SAR to cover a variety of conformationally modified side chains within the 9-keto and 9-hydroxyl tricyclic structures. Of the compounds described here, those with a seven-atom long side chain substituted with a cyclopentyl ring at C1′ position have very high affinities for both CB1 and CB2 (0.97 nM < Ki < 5.25 nM), with no preference for either of the two receptors. However, presence of the smaller cyclobutyl group at the C1′ position leads to an optimal affinity and selectivity interaction with CB1. Thus, two of the C1′-cyclobutyl analogues, namely, (6aR,10aR)-3-(1-hexyl-cyclobut-1-yl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one and (6aR,9R,10aR)-3-(1-hexyl-cyclobut-1-yl)-6a,7,8,9,10,10a-hexahydro-6,6-dimethyl-6H-dibenzo[b,d]pyran-1,9 diol (7e-β, AM2389), exhibited remarkably high affinities (0.84 and 0.16 nM, respectively) and significant selectivities (16- and 26-fold, respectively) for CB1. Compound 7e-β was found to exhibit exceptionally high in vitro and in vivo potency with a relatively long duration of action.Keywords
This publication has 43 references indexed in Scilit:
- Heteroadamantyl CannabinoidsJournal of Medicinal Chemistry, 2010
- C1‘-Cycloalkyl Side Chain Pharmacophore in TetrahydrocannabinolsJournal of Medicinal Chemistry, 2007
- Natural cannabinoids: Templates for drug discoveryLife Sciences, 2005
- The role of halogen substitution in classical cannabinoids: A CB1 pharmacophore modelThe AAPS Journal, 2004
- Pharmacophoric Requirements for the Cannabinoid Side Chain. Probing the Cannabinoid Receptor Subsite at C1‘Journal of Medicinal Chemistry, 2003
- A New Ring-Forming Methodology for the Synthesis of Conformationally Constrained Bioactive MoleculesChemistry Letters, 2001
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Semianalytical treatment of solvation for molecular mechanics and dynamicsJournal of the American Chemical Society, 1990
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973
- New Analogs of Tetrahydrocannabinol. XIXJournal of the American Chemical Society, 1949